Lyrica Sales Data
| Rank 19 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Lyrica U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 19 ( 2) |
$553,016 | 8.10% | 2,074 | 0.29% |
| Q4 2012 | 21 | $511,571 | 2.36% | 2,068 | 2.17% |
| Q3 2012 | 21 (7) |
$499,777 | 9.94% | 2,024 | 2.12% |
| Q2 2012 | 28 | $454,575 | -0.78% | 1,982 | -0.45% |
| Q1 2012 | 28 (3) |
$458,171 | 6.04% | 1,991 | -2.02% |
| Q4 2011 | 31 ( 2) |
$432,070 | 1.23% | 2,032 | 1.25% |
| Q3 2011 | 29 | $426,822 | -2.94% | 2,007 | -2.10% |
| Q2 2011 | 29 (1) |
$439,764 | 0.72% | 2,050 | 0.74% |
| Q1 2011 | 30 | $436,615 |  |
2,035 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
See Also
Related News
| Date | Article |
|---|---|
| May 4, 2012 | Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy |
| April 29, 2009 | Common Drug Eases Restless Legs Syndrome |
